Hangzhou Biotest Biotech Co Ltd
SSE:688767
Dividends
Dividend Yield
Hangzhou Biotest Biotech Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Hangzhou Biotest Biotech Co Ltd
Payout Ratio
Hangzhou Biotest Biotech Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Hangzhou Biotest Biotech Co Ltd is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Hangzhou Biotest Biotech Co Ltd
| Average Annual Return | -13.87% |
| Standard Deviation of Annual Returns | 18.15% |
| Max Drawdown | -81% |
| Market Capitalization | 5.5B CNY |
| Shares Outstanding | 149 330 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Hangzhou Biotest Biotech Co Ltd's latest stock split occurred on Jun 6, 2025
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Hangzhou Biotest Biotech Co Ltd traded at 46.59 per share. Afterward, the share price was about 32.14.
The adjusted shares began trading on Jun 6, 2025. This was the only stock split in Hangzhou Biotest Biotech Co Ltd's history.
